These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5897224)

  • 41. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
    Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994-2001)].
    Wagenlehner E; Niemetz A; Naber G
    Urologe A; 2003 Jan; 42(1):13-25. PubMed ID: 12574879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
    Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
    Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
    Arya SC; Agarwal N
    BJU Int; 2009 Apr; 103(7):994-5. PubMed ID: 19302136
    [No Abstract]   [Full Text] [Related]  

  • 45. [Inflammation of the salivary glands attributed to the use of nitrofurantoin].
    Slappendel AM; Feenstra J; Stricker BH
    Ned Tijdschr Geneeskd; 1997 Feb; 141(7):342-3. PubMed ID: 9132610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
    Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitrofurantoin and pregnancy.
    Cimolai N; Cimolai T
    CMAJ; 2007 Jun; 176(13):1860-1. PubMed ID: 17576987
    [No Abstract]   [Full Text] [Related]  

  • 48. [Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus].
    Ruxer J; Mozdzan M; Loba J; Markuszewski L
    Wiad Lek; 2007; 60(5-6):235-40. PubMed ID: 17966887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database.
    Goettsch WG; Janknegt R; Herings RM
    Br J Clin Pharmacol; 2004 Aug; 58(2):184-9. PubMed ID: 15255801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to quinolones in pathogens causing urinary tract infections.
    Kapoor H; Aggarwal P
    J Commun Dis; 1997 Sep; 29(3):263-7. PubMed ID: 9465532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nitrofurantoin lung injury.
    Bidad K; Harries-Jones R
    Age Ageing; 2004 Jul; 33(4):414-5. PubMed ID: 15226112
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug sensitivity of urinary pathogenic bacteria.
    Rayan AJ; Bai KT; Unnisa A; Lalitha K
    J Indian Med Assoc; 1978 Jun; 70(11):245-7. PubMed ID: 712081
    [No Abstract]   [Full Text] [Related]  

  • 53. Agranulocytosis associated with nitrofurantoin therapy.
    Roberts AD; Neelamegam M
    Ann Pharmacother; 2005 Jan; 39(1):198. PubMed ID: 15572603
    [No Abstract]   [Full Text] [Related]  

  • 54. [Summary of the 'Urinary tract infections' guideline (first revision) of the Dutch College of General Practitioners].
    Wiersma TJ; Timmermans AE
    Ned Tijdschr Geneeskd; 2001 Apr; 145(15):735-9. PubMed ID: 11332256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bacteria causing urinary tract infections and their sensitivity to antibiotics and chemotherapeutics].
    Schmid W
    Med Welt; 1966 May; 22():1231-9. PubMed ID: 5984501
    [No Abstract]   [Full Text] [Related]  

  • 56. Potential unreliability of nitrofurantoin disks in susceptibility testing.
    Hoo R; Drew WL
    Antimicrob Agents Chemother; 1974 Jun; 5(6):607-10. PubMed ID: 15825413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Furadantin as a urinary tract antiseptic].
    PALMLOV A; TUNEVALL G
    Sven Lakartidn; 1956 Nov; 53(44):2864-75. PubMed ID: 13380778
    [No Abstract]   [Full Text] [Related]  

  • 58. The combined activity of nitrofurantoin and antibiotics on strains of resistant bacteria commonly found in urinary tract infections.
    CLAPPER WE; SUN C; MEADE GH
    Antibiot Chemother (Northfield); 1957 Apr; 7(4):193-9. PubMed ID: 24544330
    [No Abstract]   [Full Text] [Related]  

  • 59. Re: Nitrofurantoin vs Other Prophylactic Agents in Reducing Recurrent Urinary Tract Infections in Adult Women: A Systematic Review and Meta-Analysis.
    Griebling TL
    J Urol; 2017 May; 197(5):1277-1278. PubMed ID: 29539907
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of furadantin on gram-negative bacteria cultured from the urinary tract].
    Fijalka M
    Pol Tyg Lek; 1966 Aug; 21(31):1201-2. PubMed ID: 5341178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.